Diabetes Technology and Therapeutics Impact Factor, Quartile, Indexing, Ranking

Diabetes Technology and Therapeutics (DTr) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Mary Ann Liebert. The Print-ISSN of Diabetes Technology and Therapeutics is 1520-9156 and its abbreviation is Dialogues Hum Geogr.

The Publicaiton fees (APC) is $3,600 USD.

Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.

Diabetes Technology & Therapeutics coverage includes:

• Detection and prevention of long-term micro- and macrovascular complications
• Breakthrough technologies and new therapeutic drug classes
• Behavioral aspects and approaches to diabetes care
• The latest advancement and applications of new and emerging technologies, including:
  • Alternate insulin delivery methods
  • Continuous glucose monitoring
  • Artificial pancreas
  • Computerized case management/telemedicine
  • New insulins with ultra-rapid onset of action
  • Detection and prevention of hypoglycemia

• Journal Website
• PubMed
• Scopus
• SCImago